Case study: Innomar’s role in addressing a critical drug shortage
By Innomar Strategies
When a critical shortage of a specialty drug product created a risk to patient access in Canada, the manufacturer required timely support across quality assurance, logistics, and patient support. This case study outlines how Innomar worked alongside the client and Health Canada to support requirements, facilitate compliant importation and distribution, and establish the operational readiness needed to maintain continuity of care for patients.
The information provided in this piece does not constitute legal or medical advice. Innomar Strategies Inc. and its parent Cencora, Inc. strongly encourage the audience to review available information related to the topics discussed to rely on their own experience and expertise in making decisions related thereto. Further, the contents of this piece are owned by Innomar Strategies, and reproduction is not permitted without the consent of Innomar Strategies.
